Cspc Zhongqi Pharmaceutical Technology Co., Ltd.

This study is testing whether a new antibody injection called CM326 can help control moderate to severe Chronic Obstructive Pulmonary Disease (COPD). Researchers want to see if it reduces the number of serious symptom flare-ups and improves lung function and quality of life. Abou…

This study is testing whether a new drug called glumetinib, when combined with an existing chemotherapy (docetaxel), can help control advanced stomach, gastroesophageal, and other solid tumors that have a specific genetic feature (MET overexpression/amplification). It aims to fin…

This study is testing whether combining two existing drugs works better than current options for advanced neuroendocrine tumors of the gut and pancreas. It's for patients whose cancer has spread and who have not yet received any systemic cancer treatment. The main goals are to se…

This trial is testing whether combining a drug called sirolimus with several newer antibody-drug conjugates (ADCs) is safe and effective for people with advanced solid tumors that have spread or can't be removed by surgery. Researchers will enroll about 444 patients to find the b…

This is an early-stage study to check the safety of a new, unnamed drug called SYH2085. It will involve 74 healthy Chinese adults to see how their bodies react to and process a single dose. The main goal is to find out what side effects might occur and how the drug behaves in the…